Selective Hsp90ß inhibitors for the treatment of cancer


Provided by: The Center for Advancing Innovation ; University of Kansas
Tags: anti-cancer cancer Breast Cancer GPCR Cell Line
Short Description:

This technology pertains to highly selective Hsp90ß inhibitors that can be developed for the treatment of a variety of diseases that result from increased Hsp90 expression.

Projects based on this Technology

Start New Project